Holen Sie sich die Stockscreener-App
40.00
0.38%
0.15
Schlusskurs vom Vortag:
$39.85
Offen:
$40.22
24-Stunden-Volumen:
663.48K
Relative Volume:
1.64
Marktkapitalisierung:
$1.14B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.47M
KGV:
-7.1463
EPS:
-5.5973
Netto-Cashflow:
$-73.92M
1W Leistung:
+5.68%
1M Leistung:
+21.29%
6M Leistung:
+70.29%
1J Leistung:
+80.02%
1-Tages-Spanne:
$39.27
$41.26
1-Wochen-Bereich:
$36.30
$41.26
52-Wochen-Spanne:
$16.54
$41.70
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Firmenname
Lenz Therapeutics Inc
Sektor
Branche
Telefon
858-925-7000
Adresse
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Vergleichen Sie LENZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
40.00 | 1.11B | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-03-18 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Outperform |
| 2024-08-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-15 | Eingeleitet | William Blair | Outperform |
| 2024-04-10 | Eingeleitet | Citigroup | Buy |
| 2024-03-27 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-23 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-02-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | Herabstufung | Cowen | Outperform → Market Perform |
| 2023-01-25 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-06 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-04-14 | Eingeleitet | BTIG Research | Buy |
| 2022-03-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-07-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
News impact scoring models applied to LENZ Therapeutics Inc.Market Sentiment Report & Real-Time Buy Signal Notifications - Newser
Real time breakdown of LENZ Therapeutics Inc. stock performanceQuarterly Market Summary & Verified Momentum Watchlists - Newser
Analyzing LENZ Therapeutics Inc. with risk reward ratio charts2025 Valuation Update & Trade Opportunity Analysis Reports - Newser
How to build a dashboard for LENZ Therapeutics Inc. stockQuarterly Market Summary & High Return Stock Watch Alerts - Newser
Relative strength of LENZ Therapeutics Inc. in sector analysis2025 Key Highlights & Detailed Earnings Play Alerts - Newser
LENZ Therapeutics Inc. stock outlook for YEARGold Moves & Weekly Chart Analysis and Guides - Newser
What MACD and RSI say about LENZ Therapeutics Inc.Market Performance Summary & Verified Chart Pattern Trade Signals - Newser
Using data tools to time your LENZ Therapeutics Inc. exitEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Has LENZ Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewJuly 2025 Earnings & Reliable Entry Point Alerts - Newser
Detecting support and resistance levels for LENZ Therapeutics Inc.Weekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
Will LENZ Therapeutics Inc. bounce back from current supportWeekly Investment Recap & Smart Money Movement Tracker - Newser
Traders Consider Averaging Down in LENZ Therapeutics Inc.July 2025 Rallies & High Win Rate Trade Tips - 선데이타임즈
Developing predictive dashboards with LENZ Therapeutics Inc. data2025 Market Trends & Weekly Consistent Profit Watchlists - Newser
Full technical analysis of LENZ Therapeutics Inc. stock2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
LENZ Therapeutics Inc. Rebound Backed by Sentiment ShiftQuarterly Portfolio Summary & Real-Time Market Sentiment Reports - classian.co.kr
First Week of April 2026 Options Trading For Lenz Therapeutics - Nasdaq
Trend analysis for LENZ Therapeutics Inc. this weekJuly 2025 Review & Entry Point Confirmation Alerts - Newser
Will LENZ Therapeutics Inc. benefit from macro trendsWeekly Risk Report & Stock Market Timing Techniques - Newser
How to manage a losing position in LENZ Therapeutics Inc.Earnings Growth Report & Risk Managed Investment Entry Signals - Newser
Is a relief rally coming for LENZ Therapeutics Inc. holdersRate Hike & High Yield Equity Trading Tips - Newser
What makes LENZ Therapeutics Inc. stock price move sharplyQuarterly Performance Summary & AI Driven Price Forecasts - Newser
Has LENZ Therapeutics Inc. found a price floorWeekly Trend Report & AI Powered Market Entry Strategies - Newser
What high frequency data says about LENZ Therapeutics Inc.July 2025 Update & Weekly Stock Breakout Alerts - Newser
Using R and stats models for LENZ Therapeutics Inc. forecastingQuarterly Risk Review & Free Weekly Chart Analysis and Trade Guides - Newser
What MACD signals say about LENZ Therapeutics Inc.Portfolio Growth Summary & Community Shared Stock Ideas - Newser
Why LENZ Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Spike Watch & Expert Approved Trade Ideas - 선데이타임즈
LENZ Therapeutics Inc.’s volatility index tracking explained2025 Key Lessons & Consistent Growth Equity Picks - Newser
Short interest data insights for LENZ Therapeutics Inc.2025 Market Overview & Daily Oversold Bounce Ideas - Newser
Applying big data sentiment scoring on LENZ Therapeutics Inc.July 2025 Volume & Smart Allocation Stock Reports - Newser
What earnings revisions data tells us about LENZ Therapeutics Inc.Weekly Gains Summary & High Return Trade Opportunity Guides - Newser
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - NDTV Profit
Will LENZ Therapeutics Inc. rebound enough to break evenJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Using data models to predict LENZ Therapeutics Inc. stock movement2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - Newser
Does LENZ Therapeutics Inc. qualify in momentum factor screeningQuarterly Profit Report & Risk Controlled Swing Alerts - Newser
Is LENZ Therapeutics Inc. a cyclical or defensive stockEarnings Performance Report & Accurate Trade Setup Notifications - thegnnews.com
Lenz Therapeutics stock hits 52-week high at 40.97 USD By Investing.com - Investing.com Canada
Lenz Therapeutics stock hits 52-week high at 40.97 USD - Investing.com
FDA Approves Vizz Eye Drops for Instant Near Vision Improvement - AInvest
Lenz Therapeutics shares rise 2.15% premarket after Lotus Pharmaceuticals reported a 6% revenue increase in the U.S. and Southeast Asia. - AInvest
What the charts say about LENZ Therapeutics Inc. todayJuly 2025 Levels & Risk Managed Investment Signals - Newser
Momentum Screeners Rank LENZ Therapeutics Inc. in Top 5 TodayAI Forecast for Trending Stocks Indicates Upside - beatles.ru
Evaluating LENZ Therapeutics Inc. with trendline analysisNeural Network Based Equity Prediction System - Newser
LENZ Therapeutics Scores Relative Strength Rating Upgrade - Investor's Business Daily
LENZ Therapeutics: Evaluate Stock Surge - timothysykes.com
LENZ Therapeutics Soars 11.6% on Explosive Intraday Rally: Technical Breakout or Speculative Surge? - AInvest
LENZ Therapeutics Soars 12.48% on Intraday Frenzy: Is This a Breakout or a Bubble? - AInvest
Finanzdaten der Lenz Therapeutics Inc-Aktie (LENZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lenz Therapeutics Inc-Aktie (LENZ) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
69,949 |
2,762,986 |
977,963 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
30,628 |
1,181,049 |
1,400,220 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
15,085 |
581,694 |
962,878 |
| Versant Venture Capital VI, L. | 10% Owner |
Jul 10 '25 |
Sale |
34.00 |
191,376 |
6,506,784 |
1,575,899 |
| Versant Venture Capital VI, L. | 10% Owner |
Jun 27 '25 |
Sale |
30.46 |
200,000 |
6,093,000 |
1,767,275 |
| Versant Venture Capital VI, L. | 10% Owner |
Jun 20 '25 |
Sale |
30.25 |
133,924 |
4,051,201 |
1,967,275 |
| Versant Venture Capital VI, L. | 10% Owner |
Jun 20 '25 |
Sale |
30.35 |
100,877 |
3,061,617 |
1,047,912 |
| Versant Venture Capital VI, L. | 10% Owner |
Jun 18 '25 |
Sale |
29.95 |
100,000 |
2,995,000 |
1,148,789 |
| Versant Venture Capital VI, L. | 10% Owner |
Jun 10 '25 |
Sale |
29.00 |
350,000 |
10,150,000 |
1,248,789 |
| Olsson Shawn | Chief Commercial Officer |
Apr 09 '25 |
Option Exercise |
2.08 |
1,400 |
2,912 |
4,733 |
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):